J&J’s Flu Drug Flop Shows How Difficult It Is to Treat Viruses

(Bloomberg) -- Johnson & Johnson halted the development of a new flu drug after a study suggested it wouldn’t work, a sign of how difficult it is to create treatments for viral infections as the wo...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.